{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:46:39Z","timestamp":1762508799801,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Tianjin Key Medical Discipline(Specialty) Construction Project"},{"name":"Tianjin Health Science and Technology Project","award":["No. TJWJ2021MS010","No. TJWJ2021MS034"],"award-info":[{"award-number":["No. TJWJ2021MS010","No. TJWJ2021MS034"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The Baveno VI criteria (B6C) have been recommended to screen high-risk varices (HRV) in patients with liver cirrhosis to avoid the use of esophagogastroduodenoscopy (EGD). Due to conservative nature of B6C and the general unavailability of transient elastography in the medical institutions, clinical application of B6C is restricted. We aimed to optimize B6C and attempted to replace the liver stiffness (LS) score with other parameters that could help patients avoid EGD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 1,188 patients with compensated cirrhosis were analyzed and divided into the training cohort (TC) and validating cohort (VC) by the split-sample method. Variables were selected to develop new criteria in the TC before verification in the VC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The parameters of age \u2265\u200950\u00a0years, LS, platelet count (PLT), and spleen area (SA) were independently associated with HRV. The risk of HRV was 2.39 times greater in patients over 50\u00a0years, hence alternative B6C (AB6C) and modified B6C (MB6C) criteria were built based on age. MB6C was built by adjusting the cut-off value of LS and PLT (patients aged &lt;\u200950\u00a0years with PLT\u2009&gt;\u2009100\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L and LS\u2009&lt;\u200930\u00a0kPa; patients aged \u2265\u200950\u00a0years with a combined PLT\u2009&gt;\u2009125\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L and LS\u2009&lt;\u200920\u00a0kPa). MB6C helped avoid EGD in 310 (51.2%) patients, whereas 7 (2.3%) cases of HRV were missed. The predicting performance HRV showed no statistical difference between PLT, SA, or LS. SA was selected to replace LS and in the built AB6C (patients aged &lt;\u200950\u00a0years with PLT\u2009&gt;\u2009100\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L and SA\u2009&lt;\u200955\u00a0cm<jats:sup>2<\/jats:sup>; patients aged \u2265\u200950\u00a0years with a combined PLT\u2009&gt;\u2009125\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L and SA\u2009&lt;\u200944\u00a0cm<jats:sup>2<\/jats:sup>). Using AB6C avoided 297 (49.1%) EGDs with a total of 8 (2.7%) cases of HRV that were missed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our novel MB6C and AB6C were stratified by age and provided excellent performance for ruling out HRV, which performed better than B6C and EB6C (expanded B6C) in helping to avoid EGD screening.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Clinical trial registration number<\/jats:title>\n                <jats:p>ChiCTR-DDD-17013845.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12072-022-10359-y","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T15:03:13Z","timestamp":1655823793000},"page":"936-943","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Modified and alternative Baveno VI criteria based on age for ruling out high-risk varices in patients with compensated cirrhosis"],"prefix":"10.1007","volume":"16","clinical-trial-number":[{"clinical-trial-number":"chictr-ddd-17013845","registry":"10.18810\/chictr"}],"author":[{"given":"Lili","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0100-417X","authenticated-orcid":false,"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,21]]},"reference":[{"issue":"1","key":"10359_CR1","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/hep.28906","volume":"65","author":"G Garcia-Tsao","year":"2017","unstructured":"Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology 2017;65(1):310\u2013335","journal-title":"Hepatology"},{"issue":"15","key":"10359_CR2","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1056\/NEJM198810133191505","volume":"319","author":"North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices","year":"1988","unstructured":"North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 1988;319(15):983\u2013989","journal-title":"N Engl J Med"},{"issue":"4","key":"10359_CR3","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.jhep.2010.06.004","volume":"53","author":"R de Franchis","year":"2010","unstructured":"de Franchis R, Baveno V Faculty. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010;53(4):762\u2013768","journal-title":"J Hepatol"},{"issue":"1","key":"10359_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1053\/gast.2000.8555","volume":"119","author":"M Primignani","year":"2000","unstructured":"Primignani M, Carpinelli L, Preatoni P, Battaglia G, Carta A, Prada A, et al. Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology 2000;119(1):181\u2013187","journal-title":"Gastroenterology"},{"issue":"3","key":"10359_CR5","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"R de Franchis","year":"2015","unstructured":"de Franchis R, Faculty BVI. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol 2015;63(3):743\u2013752","journal-title":"J Hepatol"},{"issue":"8","key":"10359_CR6","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/liv.13379","volume":"37","author":"P Jangouk","year":"2017","unstructured":"Jangouk P, Turco L, De Oliveira A, Schepis F, Villa E, Garcia-Tsao G. Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis. Liver Int 2017;37(8):1177\u20131183","journal-title":"Liver Int"},{"issue":"5","key":"10359_CR7","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.jhep.2016.06.021","volume":"65","author":"JB Maurice","year":"2016","unstructured":"Maurice JB, Brodkin E, Arnold F, Navaratnam A, Paine H, Khawar S, et al. Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices. J Hepatol 2016;65(5):899\u2013905","journal-title":"J Hepatol"},{"issue":"6","key":"10359_CR8","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1111\/liv.14373","volume":"40","author":"MI Gaete","year":"2020","unstructured":"Gaete MI, D\u00edaz LA, Arenas A, Gonz\u00e1lez K, Cattaneo M, Fuster F, et al. Baveno VI and expanded Baveno VI criteria successfully predicts the absence of high-risk gastro-oesophageal varices in a Chilean cohort. Liver Int 2020;40(6):1427\u20131434","journal-title":"Liver Int"},{"issue":"6","key":"10359_CR9","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1002\/hep.29363","volume":"66","author":"S Augustin","year":"2017","unstructured":"Augustin S, Pons M, Maurice JB, Bureau C, Stefanescu H, Michel Ney M, et al. Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease. Hepatology 2017;66(6):1980\u20131988","journal-title":"Hepatology"},{"issue":"3","key":"10359_CR10","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41395-018-0265-7","volume":"114","author":"C Moctezuma-Velazquez","year":"2019","unstructured":"Moctezuma-Velazquez C, Saffioti F, Tasayco-Huaman S, Casu S, Mason Andrew, Roccarina D, et al. Non-invasive prediction of high-risk varices in patients with primary biliary cholangitis and primary sclerosing cholangitis. Am J Gastroenterol 2019;114(3):446\u2013452","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10359_CR11","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.jhep.2020.06.042","volume":"73","author":"KI Zheng","year":"2020","unstructured":"Zheng KI, Liu C, Li J, Zhao LL, Zheng MH, Wang FM, et al. Validation of Baveno VI and expanded Baveno VI criteria to identify high-risk varices in patients with MAFLD-related compensated cirrhosis. J Hepatol 2020;73(6):1571\u20131573","journal-title":"J Hepatol"},{"issue":"9930","key":"10359_CR12","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","volume":"383","author":"EA Tsochatzis","year":"2014","unstructured":"Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet 2014;383(9930):1749\u20131761","journal-title":"Lancet"},{"issue":"1","key":"10359_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1443-1661.2009.00929.x","volume":"22","author":"T Tajiri","year":"2010","unstructured":"Tajiri T, Yoshida H, Obara K, Onji M, Kage M, Kitano S, et al. General rules for recording endoscopic findings of esophagogastric varices (2nd edition). Dig Endosc 2010;22(1):1\u20139","journal-title":"Dig Endosc"},{"issue":"6","key":"10359_CR14","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1055\/s-0031-1281856","volume":"32","author":"A Berzigotti","year":"2011","unstructured":"Berzigotti A, Piscaglia F. Ultrasound in portal hypertension-part 1. Ultraschall Med 2011;32(6):548\u2013571","journal-title":"Ultraschall Med"},{"issue":"4","key":"10359_CR15","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.cgh.2020.06.022","volume":"19","author":"A Berger","year":"2021","unstructured":"Berger A, Ravaioli F, Farcau O, Festi D, Stefanescu H, Buisson F, et al. Including ratio of platelets to liver stiffness improves accuracy of screening for esophageal varices that require treatment. Clin Gastroenterol Hepatol 2021;19(4):777\u2013787.e17","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10359_CR16","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1053\/j.gastro.2018.11.053","volume":"156","author":"D Thabut","year":"2019","unstructured":"Thabut D, Bureau C, Layese R, Val\u00e9rie Bourcie V, Hammouche M, Cagnot C, et al. Validation of Baveno VI criteria for screening and surveillance of esophageal varices in patients with compensated cirrhosis and a sustained response to antiviral therapy. Gastroenterology 2019;156(4):997\u20131009.e5","journal-title":"Gastroenterology"},{"issue":"1","key":"10359_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/jcu.1870190106","volume":"19","author":"H Ishibashi","year":"1991","unstructured":"Ishibashi H, Higuchi N, Shimamura R, Hirata Y, Kudo J, Niho Y. Sonographic assessment and grading of spleen size. J Clin Ultrasound 1991;19(1):21\u201325","journal-title":"J Clin Ultrasound"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10359-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-022-10359-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10359-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T12:36:51Z","timestamp":1659530211000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-022-10359-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,21]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["10359"],"URL":"https:\/\/doi.org\/10.1007\/s12072-022-10359-y","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"type":"print","value":"1936-0533"},{"type":"electronic","value":"1936-0541"}],"subject":[],"published":{"date-parts":[[2022,6,21]]},"assertion":[{"value":"17 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Lili Zhao, Ting Wang, Chunxia Guo, Li Zhou, Ping Han, Chunyan Wang, Ying Ma, Jing Wang, Min Gao and Jia Li declare that they have no conflict of interest related to this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the ethics committee of the Tianjin Second People\u2019s Hospital and was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained and details that might disclose identity were omitted.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}